Author

Celia Kessler

ORCID 0000-0002-3729-0318Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adrian J. LloydiD· 1 shared Catherine E RowlandiD· 1 shared Christopher Gerard DowsoniD· 1 shared David I. RoperiD· 1 shared Dom BelliniiD· 1 shared Hector NewmaniD· 1 shared James M. WagstaffiD· 1 shared Katerine Van RietschoteniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adrian J. LloydORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Discovery and chemical optimisation of a Potent, Bi-cyclic (Bicycle(R)) Antimicrobial Inhibitor of Escherichia coli PBP3

Catherine E Rowland, Hector Newman, Tazmin T. Martin, Rachel Dods, Nikolaos Bournakas, James M. Wagstaff, Nick Lewis, Steven J. Stanway, Matthew R. Balmforth, Celia Kessler, Katerine Van Rietschoten, Dom Bellini, David I. Roper, Adrian J. Lloyd, Christopher Gerard Dowson, , Michael J. Dawson

This study discovers and optimizes bicyclic peptide inhibitors of E. coli PBP3, showing high-affinity binding and broad-spectrum antimicrobial activity.

Communications Biology · May 28, 2025Peer-reviewedBiochemistry